Continuous subcutaneous insulin infusion (CSII), multiple injections (MI) and conventional insulin therapy (CT) in self‐selecting insulin‐dependent diabetic patients. A comparison of metabolic control, acute complications and patient preferences

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Journal of Internal Medicine

• Publication date

  1990-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2796.1990.tb00263.xPMID 2254715
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A crossover comparison of continuous insulin infusion and conventional injection treatment of type I diabetes.

  2009cited by this paper
• Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study.

  1986cited by this paper
• Assessment of Reliability of Patients Performing SMBG With a Portable Reflectance Meter With Memory Capacity (M-Glucometer)

  1986cited by this paper
• Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes.

  1986cited by this paper
• Rarity of a Marked “Dawn Phenomenon” in Diabetic Subjects Treated by Continuous Subcutaneous Insulin Infusion

  1985cited by this paper
• A Feasibility Study of the Use of Continuous Subcutaneous Insulin Infusion in a Diabetic Clinic: Patients' Choice of Treatment

  1984cited by this paper
• Blood glucose control and the evolution of diabetic retinopathy and albuminuria. A preliminary multicenter trial.

  1984cited by this paper
• Reliability of blood glucose monitoring by patients with diabetes mellitus.

  1984cited by this paper
• Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics.

  1983cited by this paper
• Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control.

  1983cited by this paper
• Comparison Between Continuous Subcutaneous Insulin Infusion and Multiple Injections of Insulin: A One-Year Prospective Study

  1982cited by this paper
• Treatment of insulin-dependent diabetes with multiple subcutaneous insulin injections.

  1982cited by this paper
• A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injections in insulin-dependent diabetic subjects: improved control with CSII.

  1982cited by this paper
• Improved Control in Diabetes with Continuous Subcutaneous Insulin Infusion

  1980cited by this paper
• Hyperglycaemia and diabetes mellitus.

  1976cited by this paper

• Analysis of Prevalence, Magnitude and Timing of the Dawn Phenomenon in Type 1 Diabetes: Descriptive Analysis of 2 Canadian Insulin Pump Trials in Adults and Adolescents.

  2018cites this paper
• Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.

  2018cites this paper
• Perioperative management of endocrine insufficiency after total pancreatectomy for neoplasia

  2017cites this paper
• A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial.

  2017cites this paper
• The role of practice nurses in the delivery of insulin pump therapy

  2013cites this paper
• Insulin pump therapy guidelines for China (July 2010)

  2012cites this paper
• Cochrane review: Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus

  2010cites this paper
• Impact of Intensive Therapy With Continuous Subcutaneous Insulin Infusion on Quality of Life in Patients With Type 1 Diabetes

  2010cites this paper
• Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.

  2010cites this paper
• Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus.

  2010cites this paper
• Management strategies for brittle diabetes.

  2006cites this paper
• Characteristics of basal insulin requirements by age and gender in Type-1 diabetes patients using insulin pump therapy.

  2005cites this paper
• Continuous subcutaneous insulin infusion in type 1 diabetic Saudi children. A comparison with conventional insulin therapy.

  2005cites this paper
• Current Perspectives on the Use of Continuous Subcutaneous Insulin Infusion in the Acute Care Setting and Overview of Therapy

  2004cites this paper
• Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.

  2004cites this paper
• Nutrient Intake, Glycemic Control, and Body Mass Index in Adolescents Using Continuous Subcutaneous Insulin Infusion and Those Using Traditional Insulin Therapy

  2003cites this paper
• Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy

  2003cites this paper
• Insulin pump therapy: a meta-analysis.

  2003cites this paper
• Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years

  2002cites this paper
• Comparison between continuous subcutaneous insulin infusion and multiple insulin injection therapy in type 1 diabetes mellitus: 18-month follow-up.

  2002cites this paper
• Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy.

  2001cites this paper
• Tratamento do diabetes mellitus tipo 1 com bomba de infusão subcutânea contínua de insulina e insulina lispro

  2001cites this paper
• [How should we use the short-acting insulin analog Lys-Pro in external continuous subcutaneous pumps?].

  2000cites this paper
• The use of human ultralente is limited by great intraindividual variability in overnight plasma insulin profiles

  2000cites this paper
• Efficacy of insulin pump therapy: mealtime delivery is the key factor.

  2000cites this paper
• Pharmacodynamic aspects of modes of drug administration for optimization of drug therapy.

  1999cites this paper
• [Quality of life with intensive insulin therapy: a prospective comparison of insulin pen and pump].

  1997cites this paper
• Effect of patient-selected intensive insulin therapy on quality of life.

  1997cites this paper
• Reduction in Severe Hypoglycemia With Long-Term Continuous Subcutaneous Insulin Infusion in Type I Diabetes

  1996cites this paper
• Continuous subcutaneous insulin injection for self‐care of young patients with insulin‐dependent diabetes mellitus

  1996cites this paper
• What happens in the long-term to the intensively treated IDDM patient? A four year follow-up

  1995cites this paper
• Symptoms, Hormones, and Glucose Fluxes During a Gradual Hypoglycaemia Induced by Intraperitoneal vs Venous Insulin Infusion in Type I Diabetes

  1995cites this paper
• [Current methods for optimal insulin therapy].

  1995cites this paper
• Treatment with insulin infusion pumps and ketoacidotic episodes: from physiology to troubleshooting.

  1995cites this paper
• Long-term compliance of intensified insulin therapy.

  1994cites this paper
• Experience with intraperitoneal insulin infusion from implantable programmable systems in type 1 (insulin-dependent) diabetes mellitus previously treated by external pumps.

  1993cites this paper
• Factors influencing the clinical outcome of continuous subcutaneous insulin infusion in routine practice.

  1993cites this paper